Organogenesis: Mixed ReNu Data, But Policy Tailwinds And Growth Remain Bullish (ORGO)
Organogenesis Holdings Inc. (NASDAQ: ORGO ) is a healthcare company that develops regenerative therapies for advanced wound care (AWC), surgery, and sports medicine. ORGO’s AWC segment accounts for over 90% of its revenue, but it has unfortunately contracted by around 25% YoYMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science from Ohio University, Athens, OH, USA, ...